Navigation Links
Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results
Date:11/10/2008

would have totaled $32.9 million. This represents a growth rate of approximately 9% from the pro forma combined revenue of the two companies of $30.1 million in the third quarter of 2007.

"This was a challenging quarter for the industry. The poor economic climate and tight credit conditions resulted in physicians delaying purchases and a slowdown in end-user demand," said Stephen J. Fanning, Chairman, President and Chief Executive Officer. "While Thermage revenue declined slightly from the prior year, our gross margin of 75% remains one of the highest in the industry. In addition, we exhibited good control of our operating expenses and generated approximately $1.4 million in cash from operations in the quarter."

"Reliant's growth for the quarter was the highest reported in the aesthetic energy device industry," Mr. Fanning continued. "With growing acceptance of its Fraxel products and procedures for skin resurfacing and rejuvenation earlier, Reliant generated strong growth, despite the difficult environment. We are focused on closing the Reliant transaction and completing the integration as quickly as possible. The Reliant acquisition offers significant opportunities for an expanded market presence and cost synergies."

"We anticipate that the environment will remain challenging. However, we believe that the merger of Thermage and Reliant joins the two leading brands and innovators in aesthetic device technology. Both companies have business models focused on generating substantial recurring revenue that should serve to help us weather current economic conditions and ultimately result in strengthening our leadership position in the industry," concluded Mr. Fanning.

Due to the pending completion of the Reliant acquisition and the uncertain economic environment, Thermage is withdrawing previous guidance for full year 2008.

Non-GAAP Presentation

(1) To supplement the condensed financial information presented on a GAAP basis, ma
'/>"/>

SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
2. Thermage, Inc. to Present at the Maxim Group Growth Conference
3. Thermage Announces Second Quarter 2008 Financial Results
4. Thermage, Inc. to Present at the Fourth Annual Collins Stewart Growth Conference
5. Thermage and Reliant Technologies to Join Forces
6. Thermage, Inc. to Present at the Bank of America 2008 Healthcare Conference
7. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
8. Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call
9. Thermage, Inc. Announces Initial Shipments of Cellulite Product
10. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
11. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Breast-Feeding Protected Mice From Asthma 2Health News:Breast-Feeding Protected Mice From Asthma 3Health News:Over-the-counter eardrops may cause hearing loss or damage 2Health News:Cystic Fibrosis Foundation reports upward trend for key health outcomes 2Health News:Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology 2Health News:Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology 3Health News:CEL-SCI Corporation Releases Letter to Shareholders 2Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 2Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 3Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 5Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 6Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 7Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 8Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 9Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 10
Breaking Medicine Technology:Helix BioPharma Reports On 2009 Annual General Meeting 2Helix BioPharma Reports On 2009 Annual General Meeting 3NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Sutter Medical Center Receives Certification to Use Ventricular Assist Devices as Destination Therapy 6151 1Sutter Medical Center Receives Certification to Use Ventricular Assist Devices as Destination Therapy 6151 2Cardiogenesis Reports Third Quarter 2009 Results 6149 1Cardiogenesis Reports Third Quarter 2009 Results 6149 2Cardiogenesis Reports Third Quarter 2009 Results 6149 3Cardiogenesis Reports Third Quarter 2009 Results 6149 4Cardiogenesis Reports Third Quarter 2009 Results 6149 5Cardiogenesis Reports Third Quarter 2009 Results 6149 6Cardiogenesis Reports Third Quarter 2009 Results 6149 7Neuro Kinetics Statement Concerning Newspaper Article 6147 1Neuro Kinetics Statement Concerning Newspaper Article 6147 2Neuro Kinetics Statement Concerning Newspaper Article 6147 3